Cancer drug screen based on cell cycle uncoupling

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07148009

ABSTRACT:
Checkpoint gene-defective human cells are useful for screening potential anti-tumor agents. Potential therapeutic agents are screened for the ability to cause DNA accumulation or cell death in a checkpoint gene-defective human cell.

REFERENCES:
patent: 5225326 (1993-07-01), Bresser et al.
patent: 5569824 (1996-10-01), Donehower et al.
patent: 5583034 (1996-12-01), Green et al.
patent: 5604113 (1997-02-01), White et al.
patent: 5612018 (1997-03-01), Bonyhadi et al.
patent: 5622836 (1997-04-01), Walker et al.
patent: 5659024 (1997-08-01), Reed et al.
patent: 5888764 (1999-03-01), Mountz et al.
patent: 5897999 (1999-04-01), Vogelstein et al.
patent: 5985829 (1999-11-01), Harris et al.
patent: 6214616 (2001-04-01), Vogelstein et al.
Oberhammer et al, The EMBO Journal, 1993, vol. 12, No. 9, pp. 3679-3684.
Funk et al, Trends in Biochemical Sciences, Sep. 1998, vol. 23, pp. 337-341.
Brugarolas, “Radiation-induced Cell Cycle Arrest Comprised By p21 Deficiency,” Nature, 377:552-557 (1995).
Deng, “Mice Lacking p21cip1/af1/cUndergo Normal Development, But Are Defective in G1 Checkpoint Control,” Cell, 82:675-684 (1959).
Gao, “Somatic Mutations of the WAF1/CIP1 Gene in Primary Prostate Cancer,” Oncogene, 11, 1395-1398 (1995).
Hotz, “Changes in Nuclear Chromatin Related in Apoptosis or Necrosis Induced by the DNA Topoisomerase II Inhibitor Fostriecin in MOLT-4 and HL-60 Cells are Revealed by Altered DNA Sensitivity to Denaturation,” Exp. Cell Research, 201:184-191 (1992).
Hunter, “Cyclins and Cancer II: Cyclin D and CDK Inhibitors Come of Age,” Cell, 79:573-582 (1994).
Kung, “Cell Line-Specific Differences in the Control of Cell Cycle Progression in the Absence of Mitosis,” Cell Biology, 87:9553-9557.
Gorcyzyca, “Detection of DNA Strand Breaks in Individual Apoptotic Cells by the in Situ Terminal Deoxynucleotidyl Transferase and Nick Translation Assays,” Cancer Research, 53:1945-1951 (1993).
Crissman, H.A. et al., “Normal and Perturbed Chinese Hamster Ovary Cells: Correlation of DNA, RNA and Protein Content by Flow Cytometry,” The Journal of Cell Biology, Jul. 1985, vol. 101, pp. 141-147.
Oberhammer, F. et al., “Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-β1 occurs without activation of an endonuclease”, Toxicology Letters, Dec. 1992, vol. 64/65, pp. 701-704.
Waldman et al., Cancer Research, vol. 55, pp. 5187-5190.
Bunz et al., Journal of Clin. Invest., vol. 104, pp. 263-269, 1999.
Little et al., The Journal of Biol. Chem., vol. 270, No. 19, pp. 11033-11036, May 1995.
Girinsky et al., Cancer Research, vol. 55, pp. 3726-3731, Nov. 1995.
Vidal et al., Melanoma Research, vol. 5, pp. 243-250, Aug. 1995.
Sherr, “Inhibitors of Mammalian G., Cyclin-Dependent Kinase,” Genes & Development, 9:1149-1163 (1995).
Swat, “Detection of Apoptosis of Immature CD4‘8’Thymocytes by Flow Cytometry,” J. Immunol. Meth. 137:79-87 (1991).
Woods, “Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway,” Molecular Medicine, 1:506-526 (1995).
Takahashi, I. et al., Science, vol. 246:491-494 (1989).
Diller et al., Mol. Cell Biol., vol. 10(11): 5772-5781 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cancer drug screen based on cell cycle uncoupling does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer drug screen based on cell cycle uncoupling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer drug screen based on cell cycle uncoupling will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3657330

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.